Rikesh J. Makanji, MD

Dr. Makanji obtained his MD degree from the University of Miami School of Medicine. He completed a Diagnostic Radiology Residency and Nuclear Medicine Fellowship at the University of Miami/Jackson Memorial Hospital, where he also served as Chief Fellow. He subsequently completed a Musculoskeletal Radiology Fellowship at the University of South Florida. Dr. Makanji's clinical interests include multimodality musculoskeletal imaging, nuclear medicine and body imaging.

Provider

Rikesh J. Makanji, MD

Radiology

Call 1-888-Moffitt
(1-888-663-3488)
For an Appointment

Schedule Appointment

Program
Diagnostic Imaging and Interventional Radiology

Print Print Physician Bio

Education & Training

BOARD CERTIFICATION:
  • Nuclear Medicine
  • Diagnostic Radiology
FELLOWSHIP:
  • University of Miami/Jackson Memorial Hospital - Nuclear Medicine
  • University of South Florida - Musculoskeletal Radiology
RESIDENCY:
  • University of Miami/Jackson Memorial Hospital - Diagnostic Radiology
MEDICAL SCHOOL:
  • University of Miami School of Medicine - MD
Provider

Rikesh J. Makanji, MD

Radiology

Call 1-888-Moffitt
(1-888-663-3488)
For an Appointment

Schedule Appointment

Program
Diagnostic Imaging and Interventional Radiology

Print Print Physician Bio

Publications

  • Montilla-Soler JL, Makanji R. Skeletal Scintigraphy. Cancer Control. 2017 Apr;24(2):137-146. Pubmedid: 28441368.
  • Huang Q, Schneeberger VE, Luetteke N, Jin C, Afzal R, Budzevich MM, Makanji RJ, Martinez GV, Shen T, Zhao L, Fung KM, Haura EB, Coppola D, Wu J. Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma. Mol Cancer Ther. 2016 Oct;15(10):2521-2529. Pubmedid: 27496134. Pmcid: PMC5289739.

Provider

Rikesh J. Makanji, MD

Radiology

Call 1-888-Moffitt
(1-888-663-3488)
For an Appointment

Schedule Appointment

Program
Diagnostic Imaging and Interventional Radiology

Print Print Physician Bio

Participating Trials

CLINICAL TRIAL 18613
Phase II Study of nab-Paclitaxel in Combination with Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults
Condition: Sarcoma
Intervention: Gemzar (gemcitabine); Nab-paclitaxel (Abraxane); gemcitabine
Open

If you believe you are eligible for one of these trials or studies, please call
1-888-MOFFITT (1-888-663-3488).


Provider

Rikesh J. Makanji, MD

Radiology

Call 1-888-Moffitt
(1-888-663-3488)
For an Appointment

Schedule Appointment

Program
Diagnostic Imaging and Interventional Radiology

Print Print Physician Bio